JEAN JACQUES BIENAIME

CIK 1221590 · Chief Executive Officer · last filed 2026-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$30.18M

Companies

6

Total Filings

441

Lifetime Open-Market Net

-$240.35M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMNM Director 38,915 $18.38 $715.3K $437.4K 12 2026-06-12
INCY Director 24,424 $108.53 $2.65M $320.5K 45 2026-06-10
KROS Director 16,592 $10.15 $168.4K $44.7K 6 2026-06-05
ASND Director 600 $218.06 $130.8K $206.7K 2 2026-06-01
BMRN Director 473,892 $55.95 $26.51M -$241.37M 336 2024-05-21
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Director 1,706 $3.9K 4 2014-03-10

Recent Filings · Page 18 of 45

441 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-03-06 BMRN Mixed −7,542 -$667.8K EDGAR
2018-02-28 BMRN Grant (A) +45,722 $0 EDGAR
2018-02-20 BMRN Mixed -$460.4K EDGAR
2018-02-20 BMRN Gift (G) −600 $0 EDGAR
2018-01-09 BMRN Mixed -$517.3K EDGAR
2018-01-03 INCY Grant (A) +153 $14.5K EDGAR
2018-01-02 BMRN Mixed −1,030 -$1.02M EDGAR
2017-10-03 INCY Grant (A) +124 $14.5K EDGAR
2017-09-14 Buy (P) +10,000 $40.0K
2017-07-05 INCY Grant (A) +115 $14.5K EDGAR
Showing 171180 of 441
Page 18 of 45
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.